============================================================
QUALITATIVE ERROR ANALYSIS REPORT
Generated on: 2025-08-21 14:52:54
Model: GPT-4o
Dataset: FrenchDB
============================================================

1. BASIC PERFORMANCE METRICS:
   Accuracy: 0.947
   Precision: 0.918
   Sensitivity: 0.981
   F1-Score: 0.949
   Total samples: 8594
   TP: 4214, TN: 3923, FP: 374, FN: 83

2. SMILES COMPLEXITY ANALYSIS:
   False Positives: 374 cases
     Avg combined SMILES length: 119.0 ± 118.4
   False Negatives: 83 cases
     Avg combined SMILES length: 127.3 ± 95.9
   True Positives: 4214 cases
     Avg combined SMILES length: 119.1 ± 90.8
   True Negatives: 3923 cases
     Avg combined SMILES length: 115.8 ± 71.7

3. GENE TARGET COMPLEXITY ANALYSIS:
   False Positives: 374 cases
     Avg combined gene targets: 8.8 ± 11.1
   False Negatives: 83 cases
     Avg combined gene targets: 16.0 ± 21.7
   True Positives: 4214 cases
     Avg combined gene targets: 11.3 ± 12.3
   True Negatives: 3923 cases
     Avg combined gene targets: 5.1 ± 8.1

4. ORGANISM PATTERN ANALYSIS:
   Top false positives organism pairs:
     Humans - Humans: 303 cases
     Humans - Escherichia coli (strain K12): 8 cases
     None - Humans: 4 cases
     Escherichia coli (strain K12) - Humans: 4 cases
     Human immunodeficiency virus 1 - Humans: 3 cases
   Top false negatives organism pairs:
     Humans - Humans: 41 cases
     Human immunodeficiency virus 1 - Humans: 11 cases
     Deinococcus radiodurans (strain ATCC 13939 / DSM 20539 / JCM 16871 / LMG 4051 / NBRC 15346 / NCIMB 9279 / R1 / VKM B-1422) - Humans: 7 cases
     Humans - Human immunodeficiency virus 1: 3 cases
     Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) - Humans: 2 cases

5. MOST PROBLEMATIC DRUGS:
   Tributyltin: 1.000 error rate
     (2/2 errors: 2 FP, 0 FN)
   Neomycin: 1.000 error rate
     (2/2 errors: 2 FP, 0 FN)
   Tauroursodeoxycholic acid: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Avapritinib: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Pentaerythritol tetranitrate: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Avelumab: 1.000 error rate
     (2/2 errors: 2 FP, 0 FN)
   5-fluorouridine: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Chromic nitrate: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Papaverine: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Glycyrrhizic acid: 1.000 error rate
     (2/2 errors: 2 FP, 0 FN)

6. SPECIFIC ERROR EXAMPLES:
   False Positives (predicted interaction, but no real interaction):
     1. Erenumab + Tributyltin
        Organisms: Humans - Humans
        Gene targets: 1 - 2
     2. Medazepam + Tenapanor
        Organisms: Humans - Humans
        Gene targets: 23 - 1
     3. Loprazolam + Binimetinib
        Organisms: Humans - Humans
        Gene targets: 23 - 2
     4. Sapropterin + Troleandomycin
        Organisms: Humans - Humans
        Gene targets: 4 - 3
     5. D-Levofloxacin + Hexamethonium
        Organisms: Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4) - Humans
        Gene targets: 1 - 1
   False Negatives (missed real interactions):
     1. Esomeprazole + Cyanocobalamin
        Organisms: Humans - Humans
        Gene targets: 2 - 6
     2. Eugenol + Amoxapine
        Organisms: Humans - Humans
        Gene targets: 4 - 48
     3. Dalfampridine + Eugenol
        Organisms: Humans - Humans
        Gene targets: 16 - 4
     4. Dalfampridine + Eugenol
        Organisms: Humans - Humans
        Gene targets: 16 - 4
     5. Dihydroquinidine barbiturate + Bisacodyl
        Organisms: Humans - Humans
        Gene targets: 1 - 9

7. SUMMARY INSIGHTS:
   - Model tends to over-predict interactions (more false positives than false negatives)
   - High sensitivity but lower precision - good at catching interactions but with some false alarms

Report generation completed successfully.
============================================================
